Learn how to implement the Business Continuity Management and Operational Resilience domain of CCM. Safeguard critical ...
Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a target of Rs 270, while Morgan Stanley maintains an ‘Overweight’ rating ...
Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperform.' Dr Reddy's Laboratories falls 1% after a downgrade to ...
Global brokerage firm CLSA has released its 2025 outlook for India's healthcare sector, projecting an 8-9 percent growth in the Indian pharmaceutical market, slightly outpacing the anticipated ...
On Thursday, CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results